Skip to search formSkip to main contentSkip to account menu

valofane

Known as: 2-allophenyl-2-allyl-gamma-valerolactone, valofan, allophanyl allyl valerolactone 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Urea
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
Effect of an atypical barbiturate, the 2-allophanyl-2-allyl-4-valerolactone (valofan), on exploratory behaviour and brain serotonin concentrations in mice.
This study investigates, both behaviourally and biochemically, the action of 2-allophanyl-2-allyl-4-valerolactone (Valofan) in… 
1984
1984
[Development of proxibarbal blood levels. The role of various elimination processes].
Half-lives of barbiturates are short when their lipid solubility is high but long when they are less lipophilic. Infection of… 
1979
1979
Central properties of alpha-allophanyl-alpha-allyl-gamma-valerolactone (valofan) [proceedings].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)